FDAnews
www.fdanews.com/articles/100692-transition-therapeutics-severs-partnership-with-novo-nordisk

Transition Therapeutics Severs Partnership With Novo Nordisk

November 6, 2007

Biopharmaceutical firm Transition Therapeutics Inc. has terminated a partnership with Novo Nordisk A/S to develop the Canadian company's diabetes treatment.
Canada East